skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon


The global market for bone densitometers, used mainly for assessing osteoporosis, and bone turnover marker tests, used to supplement bone mineral density measurements in diagnosing osteoporosis, is expected to reach $373.1m by 2023, a CAGR of 2.6% from 2017, according to"Bone Densitometers and Bone Turnover Marker Test," a new analyst report from Informa's Meddevicetracker.

The two leading competitors in the bone densitometry market,GE Healthcare andHologic Inc., accounted for nearly 70% of overall sales in 2017.Roche led the bone turnover tests market in 2017 with a 55.7% market share.

This market is driven by an aging population and the rising prevalence of osteoporosis, greater use of bone densitometers to assess body composition and technology upgrades. More effective bone densitometers that provide accurate bone mineral density measurements with minimal radiation exposure will also fuel growth. Limiters include lack of reimbursement for bone turnover marker tests and continued pricing pressures, a decline in osteoporosis screening and weakening of the Affordable Care Act in the US.

Click herefor a free demo ofMeddevicetracker.








電話:+81 (0)3 6273 4260